Skip to main content

Osteoporosis clinical trials at UCSF
1 in progress, 0 open to eligible people

  • Trial of Parkinson's And Zoledronic Acid

    Sorry, not yet accepting patients

    This study is a randomized (1:1) placebo-controlled trial of a single infusion of zoledronic acid-5 mg (ZA) for the prevention of fractures in men and women aged 65 years and older with Parkinson's Disease with 2 years of follow-up. A total of 3500 participants will be enrolled and randomized in the United States. Participants, follow-up outcome assessors, and study investigators will be blinded to assigned study treatment. This trial is funded by the National Institute of Aging.

Last updated: